Document Detail

Comparing vaginal and buccal misoprostol when used after methotrexate for early abortion.
MedLine Citation:
PMID:  15541407     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: The primary objective of this study was to determine if buccal misoprostol was as effective as vaginal misoprostol in medical abortions. The secondary objectives were to compare side effects and acceptability. METHODS: This was a randomized controlled trial of 600 microg misoprostol by the buccal or vaginal routes used 3 to 6 days after 50 mg/m2 methotrexate. The participants were women presenting for abortion at 49 days or less gestation. The outcome measures were the number of women who had aborted by Day 8, side effects and acceptability. RESULTS: Day 8 completion rate was 53.5% for the buccal route and 67.5% for the vaginal route (p = 0.012). Side effects were similar in the two groups except that there was more burning with the buccal route. Overall acceptability and route acceptability were similar in the two groups. CONCLUSIONS: When used after methotrexate for early abortion, the vaginal route for misoprostol is more effective and preferred to the buccal route.
Ellen R Wiebe; Konia Trouton
Related Documents :
9291347 - The effects of inadvertent exposure of mefloquine chemoprophylaxis on pregnancy outcome...
23913897 - Paternal involvement and fetal morbidity outcomes in hiv/aids: a population-based study.
23682587 - The impact of paternity on male-infant association in a primate with low paternity cert...
22925437 - Hiv and infant feeding in malawi: public health simplicity in complex social and cultur...
23153897 - The effect of immediate postpartum depot medroxyprogesterone on early breastfeeding ces...
2237577 - Adenocarcinoma of the colon occurring with intussusception in an adolescent.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Contraception     Volume:  70     ISSN:  0010-7824     ISO Abbreviation:  Contraception     Publication Date:  2004 Dec 
Date Detail:
Created Date:  2004-11-15     Completed Date:  2005-04-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0234361     Medline TA:  Contraception     Country:  United States    
Other Details:
Languages:  eng     Pagination:  463-6     Citation Subset:  IM    
Department of Family Practice, University of British Columbia, 1013-750 West Broadway, Vancouver, British Columbia, V5Z 1H9, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abortifacient Agents, Nonsteroidal / administration & dosage*
Abortion, Induced*
Administration, Buccal
Administration, Intravaginal
Gestational Age
Methotrexate / administration & dosage*
Misoprostol / administration & dosage*
Treatment Outcome
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59-05-2/Methotrexate; 59122-46-2/Misoprostol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effectiveness and acceptability of vitamin E and low-dose aspirin, alone or in combination, on Norpl...
Next Document:  Examination of changes caused by tubal sterilization in ovarian hormone secretion and uterine and ov...